Abiopharma

🔍 Tirinnanzi Martha A (Executive)

Company: Intercontinental Exchange, Inc. (ICE)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 141 shares of Common Stock at $155.0 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 5,087.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 11, 2026.
• F2: The common stock number referred in Table 1 is an aggregate number and represents 3,389 shares of common stock and 1,698 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 18, 2027.